33
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512562
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Get premium
Create a timeline
Public timelines
FAQ
About & FeedbackTermsPrivacyFAQ
Support 24/7  
CabinetGet premium
Donate

jan 1, 2013 - Ado-Trastuzumab Emtansine (T-DM1)

Description:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Added to timeline:

Cancer

ByTrinity Ozias
14 Nov 2019
0
0
302

Date:

jan 1, 2013
Now
~ 12 years ago
About & FeedbackTermsPrivacyFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL